Report
Oscar Haffen Lamm

Aelis: Full data analysis of AEF117 shows effects in a subpopulation

Following preliminary results on its phase 2b trial evaluating AEF117 in CUD, which as a reminder failed to show statistically significant effects across the binary endpoints, which measured the absolute reduction in cannabis consumption, Aelis published the final analysis of the data set and provi
Underlying
AELIS FARMA SA

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Oscar Haffen Lamm

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch